|
|
Article: BIOLASE Receives First Ever FDA Clearance for Complete Laser Root Canal Therapy; 14 Million Root Canal Procedures Performed Annually in U.S.
- Article from:
- PR Newswire
- Article date:
- January 24, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN CLEMENTE, Calif. -- BIOLASE Technology, Inc. , a medical technology company focused on the dental laser market, today announced that it has just received the first ever FDA clearance for complete hard and soft tissue laser root canal therapy. BIOLASE can now market its Waterlase(TM) technology for root canal procedures for both hard and soft tissue procedures, which will broaden the applications that dentists and specialists, such as endodontists, can perform with the YSGG laser.
This clearance covers all enamel, dentin, pulpal and diseased tissue removal, shaping and cleaning aspects of root canal therapy. This includes tooth preparation to obtain access to ...